Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia Research Letter

  

Authors:	Umrau, K.; Naganuma, K.; Gao, Q.; Dogan, A.; Kizaki, M.; Roshal, M.; Liu, Y.; Yabe, M.
Title:	Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia
Keywords:	gene mutation; human cell; major clinical study; genetics; flow cytometry; paraaortic lymph node; letter; cd3 antigen; genetic variability; gene frequency; peripheral t cell lymphoma; bone marrow biopsy; stat5 protein; stat5 transcription factor; lymphocyte; lymphocytes; fluorescence activated cell sorting; lymph node biopsy; cd19 antigen; granulocyte; cell selection; stat5b protein; eosinophilia; high throughput sequencing; gain of function mutation; hypereosinophilic syndrome; humans; human; primary cell; fetal bovine serum; stat5b protein, human; bone marrow aspiration; hypereosinophilia
Journal Title:	Leukemia and Lymphoma
Volume:	64
Issue:	1
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2023-01-01
Start Page:	238
End Page:	241
Language:	English
DOI:	10.1080/10428194.2022.2131413
PUBMED:	36308018
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141137715&doi=10.1080%2f10428194.2022.2131413&partnerID=40&md5=59bff686365fb83a4df88ae62a845dbc
Notes:	Letter -- Export Date: 1 March 2023 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/203453